For subscribers
Keep chasing drug discoveries, says veteran scientist who is stepping down from key A*Star post
Swiss stresses importance of such 'high risk, high reward' efforts for diseases like cancer
Sign up now: Get ST's newsletters delivered to your inbox
Dr Alex Matter is stepping down after nearly a decade helming the Experimental Therapeutics Centre at A*Star. Known as the father of targeted cancer therapies, he was one of the big names wooed here to drive Singapore's biomedical industry.
PHOTO: DIOS VINCOY JR FOR THE STRAITS TIMES
Singapore's health and biomedical researchers must continue to chase after discoveries and treatments for big diseases such as cancer and Alzheimer's, says the eminent scientist behind several game-changing cancer drugs.
Swiss pharma veteran Alex Matter, 79, who has also played a key role in getting the Republic's first two publicly-funded cancer drugs into clinical trials, stressed the importance of such "high risk, high reward" efforts, even as the Republic pumps more resources into areas like skin research and medical technology.
